Preclinical Ocular Models

Experimentica offers scientific know-how and expertise in preclinical ocular drug development. Our world-class scientists use multiple experimental platforms, from cell culture to complex in vivo models, to deliver the highest quality science.

Indications

Experimentica's R&D team has a broad track record in managing and executing preclinical ophthalmic efficacy, safety, and PK studies. Our disease models are designed to provide accurate results in a swift, cost-effective way.
AMD
Angiogenesis
Cornea
Diabetic Retinopathy

Development stages

In Vitro
Ex Vivo
In Vivo
Tolerability and Toxicity

Browse through all models

Experimentica has developed models, methodologies, and references to accelerate screening and validation for your innovative ocular drug candidates. We can also help you assess the feasibility of your early study designs and run pilot studies to help you make the right choice.
Laser-induced Geographic Atrophy
The mouse laser-induced geographic atrophy (GA) model resembles human early phase GA-like pathology in mice....
Toxicity responses in human retinal pigment epithelium cells
An in vitro assay to help assess and predict drug-induced toxicity on the retinal pigment epithelium (RPE) cells....
Assessment of toxicity responses in human retinoblastoma cells 
An assessment and prediction tool of a drug-induced toxicity on human retinoblastoma cells....